A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.

MLA

Bekker, Pirow J., et al. “A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 19, no. 7, July 2004, pp. 1059–66. EBSCOhost, https://doi.org/10.1359/JBMR.040305.

APA

Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004). A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, 19(7), 1059–1066. https://doi.org/10.1359/JBMR.040305

Chicago

Bekker, Pirow J, Donna L Holloway, Amy S Rasmussen, Robyn Murphy, Steven W Martin, Philip T Leese, Gregory B Holmes, Colin R Dunstan, and Alex M DePaoli. 2004. “A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 19 (7): 1059–66. doi:10.1359/JBMR.040305.